# Fimasartan in the Senior Subjects

> **NCT03246555** · PHASE3 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 241 (actual)

## Conditions studied

- The Elderly (≥ 70 Years) With Essential Hypertension

## Interventions

- **DRUG:** Fimasartan or Fimasartan/Hydrochlorothiazide
- **DRUG:** Perindopril or Perindopril/Indapamide

## Key facts

- **NCT ID:** NCT03246555
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-15
- **Primary completion:** 2019-08-19
- **Final completion:** 2019-12-09
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246555, "Fimasartan in the Senior Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03246555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*